Dr Florian Markowetz awarded a CRUK Future Leaders Prize

Dr Florian Markowetz was one of three researchers awarded a Cancer Research UK Future Leaders in Cancer Research Prize at an awards ceremony at the National Cancer Research Institute (NCRI) Cancer Conference.
This prize recognises scientists early in their career whose significant contribution to cancer research demonstrates their potential to become world-class leaders in their field.
Dr Florian Markowetz’s work is providing insights into how tumours interact with their environment. By studying the cancer’s genes in the context of the tissue around it, they are finding which signals indicate how a cancer will behave. You can find out more about his work here.
Sir Harpal Kumar, chief executive of Cancer Research UK, said: “I’m delighted to announce this year’s prize winners. These pioneering scientists are receiving awards for their extraordinary and wide-ranging contributions to cancer research. Although their work spans many different areas and types of cancer, they all share a determination to beat cancer for good. Through their pioneering work they open up new opportunities to detect and treat cancer which will help us save lives.”
Related News
See all news-
Scientists to Shine a Light on Cancer Research at Inspirational Night Walk
10th October 2025
Dr Shalini Rao, a Senior Research Associate at the Cancer Research UK Cambridge Institute, will join postgraduate students Marleen Wolke and Josephine Greenall-Ota for the Shine Night Walk on Saturday, 18 October.
Find out more -
Prof Greg Hannon shortlisted for prestigious Cancer Grand Challenge
24th September 2025
The shortlist of 12 multidisciplinary, global teams is now competing for up to £20m each, with the aim of delivering breakthroughs that no single researcher, lab, institute or country could achieve alone.
Find out more -
Future scientists join our second Cambridge LaunchPad project day
18th August 2025
Students from Thomas Clarkson Academy in Wisbech joined us for a unique opportunity to experience the world of cancer research first-hand.
Find out more